3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling Read More » August 18, 2023
3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform Read More » June 20, 2022
